Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2026

Viral Vectors and Plasmid DNA Manufacturing Market

Viral vectors and plasmid DNA manufacturing represent essential infrastructure in the gene and cell therapy value chain, enabling the delivery and expression of therapeutic genes. Viral vectors—including AAV, adenovirus, and lentivirus—are foundational to CAR-T therapies, gene editing platforms, and vaccine development due to their efficient gene transfer capabilities. Plasmid DNA, as a crucial upstream component, supports viral vector production, mRNA synthesis, and DNA vaccine development. As gene and cell therapies move toward large-scale commercialization, GMP-grade manufacturing capacity of viral vectors and plasmid DNA has become a strategic focal point for biopharma companies, CDMO platforms, and global investors.

As gene and cell therapies gain global regulatory approvals, demand for industrial-scale manufacturing of viral vectors and plasmid DNA is rapidly expanding. Blockbuster CAR-T products, AAV gene therapies, and mRNA vaccines continue to scale up, fueling the need for GMP-compliant platforms, robust quality systems, and high-purity raw materials. CDMO players are becoming the core force in industrial upgrading under the “asset-light” strategies of pharmaceutical companies. Governments worldwide are also promoting bio-manufacturing capacity through strategic funding, infrastructure support, and policy initiatives aimed at localization, modularity, and automation. The industry faces significant technical and operational barriers, including high production costs, lack of standardized processes, and stringent quality control challenges. Key bottlenecks persist in high-purity plasmid preparation and efficient viral vector production, particularly in impurity removal and yield optimization. Regulatory frameworks are evolving rapidly across different regions, requiring manufacturers to navigate diverse GMP compliance requirements and stricter approval thresholds. Additionally, the high concentration of capacity among top-tier CDMOs intensifies competition and pricing pressure, raising the market entry threshold for emerging players. The downstream market is transitioning from academic labs and early-stage biotech firms to commercial-stage biopharmaceutical companies, with order volumes scaling from grams to kilograms. AAV, LNP-mRNA, and CAR-T pipelines heavily rely on customized viral vectors and high-quality plasmids. In rare diseases, oncology, and vaccine development, demand is rising for delivery tools with enhanced expression, reduced immunogenicity, and controlled safety. This is driving the construction of scalable, modular GMP manufacturing systems that can meet precise, application-specific requirements.

This report delivers a comprehensive overview of the global Viral Vectors and Plasmid DNA Manufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Viral Vectors and Plasmid DNA Manufacturing. The Viral Vectors and Plasmid DNA Manufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Viral Vectors and Plasmid DNA Manufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Viral Vectors and Plasmid DNA Manufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Viral Vectors and Plasmid DNA Manufacturing Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 AAV

1.2.3 Lentiviruses

1.2.4 Retroviruses

1.2.5 Adenoviruses

1.2.6 DNA Plasmids

1.2.7 Other

1.3 Market by Application

1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical and Biopharmaceutical Companies

1.3.3 Academics and Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2021–2032)

2.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region

2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2021–2026)

2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2027–2032)

2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics

2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends

2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers

2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges

2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints

3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue

3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2021–2026)

3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2021–2026)

3.2 Global Top Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue

3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio

3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2025

3.5 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing Head Offices and Areas Served

3.6 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Products and Applications

3.7 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2021–2026)

4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2027–2032)

5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2021–2026)

5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2027–2032)

6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)

6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)

6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)

7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)

7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)

8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2021–2026)

8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)

9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)

9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2021–2032)

10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2021–2026)

10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Introduction

11.1.4 Thermo Fisher Scientific Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction

11.2.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.2.5 Lonza Recent Development

11.3 Azenta Life Sciences

11.3.1 Azenta Life Sciences Company Details

11.3.2 Azenta Life Sciences Business Overview

11.3.3 Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Introduction

11.3.4 Azenta Life Sciences Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.3.5 Azenta Life Sciences Recent Development

11.4 Revvity

11.4.1 Revvity Company Details

11.4.2 Revvity Business Overview

11.4.3 Revvity Viral Vectors and Plasmid DNA Manufacturing Introduction

11.4.4 Revvity Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.4.5 Revvity Recent Development

11.5 VectorBuilder

11.5.1 VectorBuilder Company Details

11.5.2 VectorBuilder Business Overview

11.5.3 VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Introduction

11.5.4 VectorBuilder Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.5.5 VectorBuilder Recent Development

11.6 Takara Bio

11.6.1 Takara Bio Company Details

11.6.2 Takara Bio Business Overview

11.6.3 Takara Bio Viral Vectors and Plasmid DNA Manufacturing Introduction

11.6.4 Takara Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.6.5 Takara Bio Recent Development

11.7 GenScript Biotech

11.7.1 GenScript Biotech Company Details

11.7.2 GenScript Biotech Business Overview

11.7.3 GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Introduction

11.7.4 GenScript Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.7.5 GenScript Biotech Recent Development

11.8 Gene Chem

11.8.1 Gene Chem Company Details

11.8.2 Gene Chem Business Overview

11.8.3 Gene Chem Viral Vectors and Plasmid DNA Manufacturing Introduction

11.8.4 Gene Chem Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.8.5 Gene Chem Recent Development

11.9 Geno Meditech

11.9.1 Geno Meditech Company Details

11.9.2 Geno Meditech Business Overview

11.9.3 Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Introduction

11.9.4 Geno Meditech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.9.5 Geno Meditech Recent Development

11.10 PackGene Biotech

11.10.1 PackGene Biotech Company Details

11.10.2 PackGene Biotech Business Overview

11.10.3 PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Introduction

11.10.4 PackGene Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.10.5 PackGene Biotech Recent Development

11.11 VIROVEK

11.11.1 VIROVEK Company Details

11.11.2 VIROVEK Business Overview

11.11.3 VIROVEK Viral Vectors and Plasmid DNA Manufacturing Introduction

11.11.4 VIROVEK Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.11.5 VIROVEK Recent Development

11.12 OriGen

11.12.1 OriGen Company Details

11.12.2 OriGen Business Overview

11.12.3 OriGen Viral Vectors and Plasmid DNA Manufacturing Introduction

11.12.4 OriGen Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.12.5 OriGen Recent Development

11.13 Vector BioLabs

11.13.1 Vector BioLabs Company Details

11.13.2 Vector BioLabs Business Overview

11.13.3 Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Introduction

11.13.4 Vector BioLabs Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

11.13.5 Vector BioLabs Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

 Table 2. Key Players of AAV

 Table 3. Key Players of Lentiviruses

 Table 4. Key Players of Retroviruses

 Table 5. Key Players of Adenoviruses

 Table 6. Key Players of DNA Plasmids

 Table 7. Key Players of Other

 Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

 Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2021–2026

 Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021–2026)

 Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (US$ Million), 2027–2032

 Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2027–2032)

 Table 14. Viral Vectors and Plasmid DNA Manufacturing Market Trends

 Table 15. Viral Vectors and Plasmid DNA Manufacturing Market Drivers

 Table 16. Viral Vectors and Plasmid DNA Manufacturing Market Challenges

 Table 17. Viral Vectors and Plasmid DNA Manufacturing Market Restraints

 Table 18. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (US$ Million), 2021–2026

 Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2021–2026)

 Table 20. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Viral Vectors and Plasmid DNA Manufacturing Revenue, 2025

 Table 21. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2025

 Table 22. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI), 2021–2026

 Table 23. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Headquarters and Area Served

 Table 24. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Products and Applications

 Table 25. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of General Availability (GA)

 Table 26. Mergers and Acquisitions, Expansion Plans

 Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (US$ Million), 2021–2026

 Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2021–2026)

 Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (US$ Million), 2027–2032

 Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2027–2032)

 Table 31. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (US$ Million), 2021–2026

 Table 32. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2021–2026)

 Table 33. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (US$ Million), 2027–2032

 Table 34. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2027–2032)

 Table 35. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 36. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026

 Table 37. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032

 Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 39. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026

 Table 40. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032

 Table 41. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 42. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2021–2026

 Table 43. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million), 2027–2032

 Table 44. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 45. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026

 Table 46. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032

 Table 47. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 48. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2021–2026

 Table 49. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (US$ Million), 2027–2032

 Table 50. Thermo Fisher Scientific Company Details

 Table 51. Thermo Fisher Scientific Business Overview

 Table 52. Thermo Fisher Scientific Viral Vectors and Plasmid DNA Manufacturing Product

 Table 53. Thermo Fisher Scientific Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 54. Thermo Fisher Scientific Recent Development

 Table 55. Lonza Company Details

 Table 56. Lonza Business Overview

 Table 57. Lonza Viral Vectors and Plasmid DNA Manufacturing Product

 Table 58. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 59. Lonza Recent Development

 Table 60. Azenta Life Sciences Company Details

 Table 61. Azenta Life Sciences Business Overview

 Table 62. Azenta Life Sciences Viral Vectors and Plasmid DNA Manufacturing Product

 Table 63. Azenta Life Sciences Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 64. Azenta Life Sciences Recent Development

 Table 65. Revvity Company Details

 Table 66. Revvity Business Overview

 Table 67. Revvity Viral Vectors and Plasmid DNA Manufacturing Product

 Table 68. Revvity Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 69. Revvity Recent Development

 Table 70. VectorBuilder Company Details

 Table 71. VectorBuilder Business Overview

 Table 72. VectorBuilder Viral Vectors and Plasmid DNA Manufacturing Product

 Table 73. VectorBuilder Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 74. VectorBuilder Recent Development

 Table 75. Takara Bio Company Details

 Table 76. Takara Bio Business Overview

 Table 77. Takara Bio Viral Vectors and Plasmid DNA Manufacturing Product

 Table 78. Takara Bio Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 79. Takara Bio Recent Development

 Table 80. GenScript Biotech Company Details

 Table 81. GenScript Biotech Business Overview

 Table 82. GenScript Biotech Viral Vectors and Plasmid DNA Manufacturing Product

 Table 83. GenScript Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 84. GenScript Biotech Recent Development

 Table 85. Gene Chem Company Details

 Table 86. Gene Chem Business Overview

 Table 87. Gene Chem Viral Vectors and Plasmid DNA Manufacturing Product

 Table 88. Gene Chem Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 89. Gene Chem Recent Development

 Table 90. Geno Meditech Company Details

 Table 91. Geno Meditech Business Overview

 Table 92. Geno Meditech Viral Vectors and Plasmid DNA Manufacturing Product

 Table 93. Geno Meditech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 94. Geno Meditech Recent Development

 Table 95. PackGene Biotech Company Details

 Table 96. PackGene Biotech Business Overview

 Table 97. PackGene Biotech Viral Vectors and Plasmid DNA Manufacturing Product

 Table 98. PackGene Biotech Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 99. PackGene Biotech Recent Development

 Table 100. VIROVEK Company Details

 Table 101. VIROVEK Business Overview

 Table 102. VIROVEK Viral Vectors and Plasmid DNA Manufacturing Product

 Table 103. VIROVEK Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 104. VIROVEK Recent Development

 Table 105. OriGen Company Details

 Table 106. OriGen Business Overview

 Table 107. OriGen Viral Vectors and Plasmid DNA Manufacturing Product

 Table 108. OriGen Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 109. OriGen Recent Development

 Table 110. Vector BioLabs Company Details

 Table 111. Vector BioLabs Business Overview

 Table 112. Vector BioLabs Viral Vectors and Plasmid DNA Manufacturing Product

 Table 113. Vector BioLabs Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (US$ Million), 2021–2026

 Table 114. Vector BioLabs Recent Development

 Table 115. Research Programs/Design for This Report

 Table 116. Key Data Information from Secondary Sources

 Table 117. Key Data Information from Primary Sources

 Table 118. Authors List of This Report

List of Figures

 Figure 1. Viral Vectors and Plasmid DNA Manufacturing Picture

 Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Type (US$ Million), 2021–2032

 Figure 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2025 vs 2032

 Figure 4. AAV Features

 Figure 5. Lentiviruses Features

 Figure 6. Retroviruses Features

 Figure 7. Adenoviruses Features

 Figure 8. DNA Plasmids Features

 Figure 9. Other Features

 Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (US$ Million), 2021–2032

 Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2025 vs 2032

 Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies

 Figure 13. Academics and Research Institutes Case Studies

 Figure 14. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered

 Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2021–2032

 Figure 16. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032

 Figure 17. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2025 vs 2032

 Figure 18. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2025

 Figure 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2025

 Figure 21. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 22. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)

 Figure 23. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 24. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 26. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)

 Figure 27. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 28. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 29. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 30. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 31. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 32. Ireland Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 33. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 34. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2021–2032)

 Figure 35. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 36. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 37. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 38. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 39. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 40. Australia & New Zealand Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 41. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 42. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)

 Figure 43. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 44. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 45. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 46. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2021–2032)

 Figure 47. Israel Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 48. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 49. UAE Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (US$ Million), 2021–2032

 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 51. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 52. Azenta Life Sciences Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 53. Revvity Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 54. VectorBuilder Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 55. Takara Bio Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 56. GenScript Biotech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 57. Gene Chem Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 58. Geno Meditech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 59. PackGene Biotech Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 60. VIROVEK Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 61. OriGen Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 62. Vector BioLabs Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2021–2026)

 Figure 63. Bottom-up and Top-down Approaches for This Report

 Figure 64. Data Triangulation

 Figure 65. Key Executives Interviewed